| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $532.00 | $562.40 | $623.20 | |
BCBS
| Facility | $0.02 | $1,558.42 | $1,759.40 | |
United
| Professional | $319.20 | $456.00 | $1,096.15 |
Oncology (prostate), exosome-based analysis of 442 small noncoding RNAs (sncRNAs) by quantitative reverse transcription polymerase chain reaction (RT-qPCR), urine, reported as molecular evidence of no-, low-, intermediate- or high-risk of prostate cancer
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $532.00 | $562.40 | $623.20 | |
BCBS
| Facility | $0.02 | $1,558.42 | $1,759.40 | |
United
| Professional | $319.20 | $456.00 | $1,096.15 |